Cargando…

Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain

Activated ezrin-radixin-moesin (ERM) proteins link the plasma membrane to the actin cytoskeleton to generate apical structures, including microvilli. Among many kinases implicated in ERM activation are the homologues LOK and SLK. CRISPR/Cas9 was used to knock out all ERM proteins or LOK/SLK in human...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaman, Riasat, Lombardo, Andrew, Sauvanet, Cécile, Viswanatha, Raghuvir, Awad, Valerie, Bonomo, Locke Ezra-Ros, McDermitt, David, Bretscher, Anthony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rockefeller University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185690/
https://www.ncbi.nlm.nih.gov/pubmed/33836044
http://dx.doi.org/10.1083/jcb.202007146
_version_ 1783704837604507648
author Zaman, Riasat
Lombardo, Andrew
Sauvanet, Cécile
Viswanatha, Raghuvir
Awad, Valerie
Bonomo, Locke Ezra-Ros
McDermitt, David
Bretscher, Anthony
author_facet Zaman, Riasat
Lombardo, Andrew
Sauvanet, Cécile
Viswanatha, Raghuvir
Awad, Valerie
Bonomo, Locke Ezra-Ros
McDermitt, David
Bretscher, Anthony
author_sort Zaman, Riasat
collection PubMed
description Activated ezrin-radixin-moesin (ERM) proteins link the plasma membrane to the actin cytoskeleton to generate apical structures, including microvilli. Among many kinases implicated in ERM activation are the homologues LOK and SLK. CRISPR/Cas9 was used to knock out all ERM proteins or LOK/SLK in human cells. LOK/SLK knockout eliminates all ERM-activating phosphorylation. The apical domains of cells lacking LOK/SLK or ERMs are strikingly similar and selectively altered, with loss of microvilli and with junctional actin replaced by ectopic myosin-II–containing apical contractile structures. Constitutively active ezrin can reverse the phenotypes of either ERM or LOK/SLK knockouts, indicating that a central function of LOK/SLK is to activate ERMs. Both knockout lines have elevated active RhoA with concomitant enhanced myosin light chain phosphorylation, revealing that active ERMs are negative regulators of RhoA. As RhoA-GTP activates LOK/SLK to activate ERM proteins, the ability of active ERMs to negatively regulate RhoA-GTP represents a novel local feedback loop necessary for the proper apical morphology of epithelial cells.
format Online
Article
Text
id pubmed-8185690
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-81856902021-12-07 Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain Zaman, Riasat Lombardo, Andrew Sauvanet, Cécile Viswanatha, Raghuvir Awad, Valerie Bonomo, Locke Ezra-Ros McDermitt, David Bretscher, Anthony J Cell Biol Article Activated ezrin-radixin-moesin (ERM) proteins link the plasma membrane to the actin cytoskeleton to generate apical structures, including microvilli. Among many kinases implicated in ERM activation are the homologues LOK and SLK. CRISPR/Cas9 was used to knock out all ERM proteins or LOK/SLK in human cells. LOK/SLK knockout eliminates all ERM-activating phosphorylation. The apical domains of cells lacking LOK/SLK or ERMs are strikingly similar and selectively altered, with loss of microvilli and with junctional actin replaced by ectopic myosin-II–containing apical contractile structures. Constitutively active ezrin can reverse the phenotypes of either ERM or LOK/SLK knockouts, indicating that a central function of LOK/SLK is to activate ERMs. Both knockout lines have elevated active RhoA with concomitant enhanced myosin light chain phosphorylation, revealing that active ERMs are negative regulators of RhoA. As RhoA-GTP activates LOK/SLK to activate ERM proteins, the ability of active ERMs to negatively regulate RhoA-GTP represents a novel local feedback loop necessary for the proper apical morphology of epithelial cells. Rockefeller University Press 2021-04-09 /pmc/articles/PMC8185690/ /pubmed/33836044 http://dx.doi.org/10.1083/jcb.202007146 Text en © 2021 Zaman et al. http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Zaman, Riasat
Lombardo, Andrew
Sauvanet, Cécile
Viswanatha, Raghuvir
Awad, Valerie
Bonomo, Locke Ezra-Ros
McDermitt, David
Bretscher, Anthony
Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain
title Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain
title_full Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain
title_fullStr Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain
title_full_unstemmed Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain
title_short Effector-mediated ERM activation locally inhibits RhoA activity to shape the apical cell domain
title_sort effector-mediated erm activation locally inhibits rhoa activity to shape the apical cell domain
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185690/
https://www.ncbi.nlm.nih.gov/pubmed/33836044
http://dx.doi.org/10.1083/jcb.202007146
work_keys_str_mv AT zamanriasat effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT lombardoandrew effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT sauvanetcecile effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT viswanatharaghuvir effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT awadvalerie effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT bonomolockeezraros effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT mcdermittdavid effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain
AT bretscheranthony effectormediatedermactivationlocallyinhibitsrhoaactivitytoshapetheapicalcelldomain